Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 11 | 2024 | 3252 | 1.300 |
Why?
|
| Insulin-Secreting Cells | 5 | 2023 | 317 | 1.090 |
Why?
|
| Pluripotent Stem Cells | 2 | 2022 | 63 | 0.970 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 53 | 0.720 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 900 | 0.610 |
Why?
|
| Twins, Dizygotic | 1 | 2018 | 182 | 0.580 |
Why?
|
| Twins, Monozygotic | 1 | 2018 | 210 | 0.570 |
Why?
|
| Stem Cells | 1 | 2021 | 546 | 0.540 |
Why?
|
| Addison Disease | 3 | 2011 | 40 | 0.510 |
Why?
|
| Autoimmunity | 3 | 2023 | 813 | 0.500 |
Why?
|
| Islets of Langerhans | 2 | 2018 | 726 | 0.460 |
Why?
|
| Steroid 21-Hydroxylase | 2 | 2011 | 30 | 0.430 |
Why?
|
| Autoantibodies | 7 | 2024 | 1346 | 0.420 |
Why?
|
| Pancreas | 3 | 2024 | 276 | 0.370 |
Why?
|
| Embryonic Stem Cells | 2 | 2021 | 106 | 0.360 |
Why?
|
| Glutamate Decarboxylase | 2 | 2022 | 160 | 0.340 |
Why?
|
| Autoimmune Diseases | 2 | 2011 | 382 | 0.310 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 172 | 0.300 |
Why?
|
| HLA-DR3 Antigen | 2 | 2022 | 79 | 0.280 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 610 | 0.270 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1701 | 0.240 |
Why?
|
| Insulin | 4 | 2023 | 2080 | 0.230 |
Why?
|
| Haplotypes | 3 | 2022 | 448 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2022 | 11 | 0.210 |
Why?
|
| Insulins | 1 | 2023 | 32 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 182 | 0.200 |
Why?
|
| Blood Glucose | 4 | 2023 | 1828 | 0.200 |
Why?
|
| HLA-DR4 Antigen | 1 | 2022 | 76 | 0.200 |
Why?
|
| Insulin Antibodies | 1 | 2022 | 102 | 0.190 |
Why?
|
| HLA Antigens | 1 | 2022 | 225 | 0.180 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 153 | 0.180 |
Why?
|
| Neuronal Outgrowth | 1 | 2020 | 10 | 0.180 |
Why?
|
| Child, Preschool | 3 | 2022 | 9118 | 0.170 |
Why?
|
| Risk | 2 | 2021 | 812 | 0.170 |
Why?
|
| Child | 6 | 2023 | 18420 | 0.170 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 377 | 0.170 |
Why?
|
| Immune System | 1 | 2021 | 172 | 0.170 |
Why?
|
| Diabetic Neuropathies | 1 | 2020 | 79 | 0.160 |
Why?
|
| Disease Progression | 3 | 2018 | 2380 | 0.160 |
Why?
|
| Humans | 18 | 2024 | 114699 | 0.160 |
Why?
|
| Adolescent | 5 | 2022 | 17853 | 0.160 |
Why?
|
| Young Adult | 3 | 2022 | 10471 | 0.150 |
Why?
|
| Seroepidemiologic Studies | 1 | 2018 | 138 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 2086 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2020 | 213 | 0.150 |
Why?
|
| Risk Factors | 5 | 2024 | 8632 | 0.150 |
Why?
|
| Mass Screening | 2 | 2018 | 1005 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2021 | 292 | 0.140 |
Why?
|
| Siblings | 1 | 2018 | 221 | 0.140 |
Why?
|
| Diseases in Twins | 1 | 2018 | 174 | 0.140 |
Why?
|
| Twins | 1 | 2018 | 240 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2021 | 387 | 0.130 |
Why?
|
| Environment | 1 | 2018 | 332 | 0.130 |
Why?
|
| Adult | 7 | 2022 | 30553 | 0.130 |
Why?
|
| Oxygen | 1 | 2020 | 854 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 1737 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3053 | 0.110 |
Why?
|
| Male | 7 | 2022 | 55606 | 0.110 |
Why?
|
| Female | 7 | 2022 | 59520 | 0.100 |
Why?
|
| HLA-DQ Antigens | 2 | 2009 | 174 | 0.100 |
Why?
|
| HLA-DR Antigens | 2 | 2009 | 219 | 0.100 |
Why?
|
| HLA-B Antigens | 1 | 2011 | 56 | 0.090 |
Why?
|
| Endocrine Cells | 1 | 2010 | 6 | 0.090 |
Why?
|
| Genotype | 3 | 2011 | 1760 | 0.090 |
Why?
|
| Alleles | 2 | 2011 | 789 | 0.090 |
Why?
|
| Insulin Infusion Systems | 2 | 2023 | 299 | 0.080 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2009 | 57 | 0.080 |
Why?
|
| Graves Disease | 1 | 2009 | 32 | 0.080 |
Why?
|
| HLA-DRB1 Chains | 1 | 2009 | 98 | 0.080 |
Why?
|
| Nuclear Family | 1 | 2009 | 49 | 0.080 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 137 | 0.080 |
Why?
|
| Homozygote | 1 | 2009 | 187 | 0.080 |
Why?
|
| HLA-D Antigens | 1 | 2008 | 34 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2009 | 186 | 0.080 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2023 | 505 | 0.080 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 343 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2011 | 1880 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 743 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 993 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2023 | 1013 | 0.060 |
Why?
|
| Family | 1 | 2009 | 589 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2013 | 1072 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1214 | 0.060 |
Why?
|
| Technology | 1 | 2023 | 79 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2024 | 6220 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 83 | 0.050 |
Why?
|
| Phantoms, Imaging | 1 | 2021 | 123 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 197 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2021 | 182 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 2096 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 4410 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 221 | 0.040 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 219 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2010 | 477 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 685 | 0.040 |
Why?
|
| Action Potentials | 1 | 2020 | 406 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 725 | 0.030 |
Why?
|
| Calcium | 1 | 2021 | 1108 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 747 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2637 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2765 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2553 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 3886 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2320 | 0.030 |
Why?
|
| HLA-B15 Antigen | 1 | 2011 | 13 | 0.020 |
Why?
|
| HLA-B8 Antigen | 1 | 2010 | 14 | 0.020 |
Why?
|
| Life Style | 1 | 2013 | 430 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 245 | 0.020 |
Why?
|
| Pedigree | 1 | 2010 | 460 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 372 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 26738 | 0.020 |
Why?
|